Multiple-Dose ARC-520 Therapy May Result In Significant And Continued Reductions In Viral Antigens And HBV RNA In Patients With Chronic HBV, Study Indicates

May 04, 2021

Gastroenterology Advisor (5/3, Aghjayan) reports researchers found “multiple-dose ARC-520 therapy may result in significant and continued reductions in viral antigens and hepatitis B virus (HBV) ribonucleic acid (RNA) in patients with chronic HBV.” The fi...